Indication
Recurrent Metastatic Nasopharyngeal Carcinoma
1 clinical trial
2 products
Clinical trial
A Randomized, Open-label, Positive-controlled, Multicenter Phase Ш Study Comparing Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing TherapyStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Product
CapecitabineProduct
Mitoxantrone